Other medications in this class include: Wegovy (semaglutide) - Same active ingredient as Ozempic, but FDA-approved for weight loss Mounjaro/Zepbound (tirzepatide) - Dual-action medication approved for diabetes (Mounjaro) and weight loss (Zepbound) Trulicity (dulaglutide) - Weekly injection for type 2 diabetes Victoza/Saxenda (liraglutide) - Available for diabetes (Victoza) and weight loss (Saxenda) Bydureon (exenatide) - Weekly injection, older medication in this class All of these work similarly by mimicking natural hormones that control blood sugar and appetite, though they may have different dosing schedules and approved uses.
Another patient with stomach sensitivity may not tolerate the same medication schedule
Some begin a tapering plan toward a lower maintenance dose
(2.3) Dosage Forms and Strengths Injection (3): o 0.25 mg/0.5 mL, 0.5 mg/0.5 mL, 1 mg/0.5 mL, 1.7 mg/0.75 mL, 2.4 mg/0.75 mL, or 7.2 mg/0.75 mL (WEGOVY HD) in a single-dose pen o 0.25 mg/0.5 mL, 0.5 mg/0.5 mL, 1 mg/0.5 mL, 1.7 mg/0.75 mL, or 2.4 mg/0.75 mL in a single-dose syringe o 9.6 mg/3 mL (3.2 mg/mL) solution in a single-patient-use pen (WEGOVY FlexTouch) that delivers four 2.4 mg/0.75 mL doses Tablets: 1.5 mg, 4 mg, 9 mg and 25 mg (3) Contraindications Warnings and Precautions Acute Pancreatitis: Has been observed in patients treated with GLP-1 receptor agonists, including WEGOVY
Our medically supervised weight loss injections are designed for adults with a BMI of 30 or higher, or 27 and above with weight-related health conditions such as high blood pressure, sleep apnea or diabetes
This misdirected frustration can lead to unnecessary protocol changes, dose adjustments, or even discontinuation of treatment that was actually working, just with a damaged supply